Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $48,970 - $53,329
-791 Closed
0 $0
Q3 2020

Feb 05, 2021

SELL
$57.43 - $63.64 $57,430 - $63,640
-1,000 Reduced 55.83%
791 $48,000
Q1 2020

Feb 09, 2021

BUY
$46.4 - $67.43 $83,102 - $120,767
1,791 New
1,791 $100,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Black Swift Group, LLC Portfolio

Follow Black Swift Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Swift Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Black Swift Group, LLC with notifications on news.